![](http://www.alamy.com/thumbs/6/F964E8D6-6937-420C-959E-15A4473A5874/2ACCA4X.jpg)
Herceptin breast cancer drug, molecular model. Herceptin (Trastuzumab) is a monoclonal antibody that binds to the HER2 receptor (human epidermal growt
Herceptin breast cancer drug, molecular model. Herceptin (Trastuzumab) is a monoclonal antibody that binds to the HER2 receptor (human epidermal growth factor receptor 2) on breast cancer cells, causing them to die during their reproductive cycle. Around a fifth of breast cancers are made up of cells that over-express this receptor, making them viable for Herceptin treatment. In this model the molecule's shape (secondary structure) is seen, comprising alpha helices (coils), beta sheets (arrows) and linking regions (lines).
Size: 4835px × 3626px
Photo credit: © EQUINOX GRAPHICS/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: 2, alpha, antibody, artwork, beta, biochemical, biochemistry, biological, biology, breast, cancer, chemical, chemistry, chemotherapy, compound, compounds, drug, epidermal, factor, growth, helices, helix, her2, herceptin, human, illustration, immunology, medical, medicine, model, molecular, molecule, molecules, monoclonal, oncology, person, pharmacological, pharmacology, protein, proteins, receptor, secondary, sheet, sheets, structure, therapy, trastuzumab, treatment, tumour